Flora Peyvandi/LinkedIn
Sep 14, 2026, 07:45
Flora Peyvandi: Building a More Equitable Future for Hemophilia Care
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
“Hemophilia care still has gaps worldwide. Restrictions can lead to low-dose prophylaxis and less protection.
Innovative therapies should close these gaps, ensuring every patient has access to effective, personalised care.
Let’s invest in health, dignity and well-being – not war.”
Other posts featuring Flora Peyvandi on Hemostasis Today.
-
Sep 14, 2026, 07:37Joseph Pierre Aboumsallem: ET Treatment Enters a New Chapter
-
Sep 14, 2026, 07:29Eric Topol – Will AI Replace Clinicians?
-
Sep 14, 2026, 07:19Ruhi Mehra: The Evolving Science of Stem Cell Enumeration
-
Sep 14, 2026, 07:05Don’t Overlook Superficial Clots – World Thrombosis Day
-
Sep 14, 2026, 06:55Transforming Hemophilia A Treatment with Bispecific Antibodies – NEJM Group
-
Sep 14, 2026, 06:51Alexander Hof: Species-Specific Roles of MPO Deficiency
-
Sep 14, 2026, 06:36Patrick Badertscher: PVI With vs Without Posterior Wall Isolation in Persistent AF
-
Sep 14, 2026, 06:31Mona Ranade: Can Mechanical Thrombectomy Play a Role in Septic Thrombophlebitis?
-
Sep 14, 2026, 06:30Alexsander Santiago: Tranexamic Acid – Why Timing Matters in Critical Bleeding